ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in...

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• ZMYND10 is implicated as a tumor suppressor in various cancers.
• The precise mechanism of ZMYND10's action in breast cancer is not fully understood.
• Investigating ZMYND10's role is crucial for understanding breast cancer progression.

Purpose of the Study:

• To elucidate the role of ZMYND10 in inhibiting breast cancer.
• To uncover the molecular mechanisms underlying ZMYND10's tumor-suppressive function.
• To identify potential therapeutic targets for breast cancer treatment.

Main Methods:

• Quantitative analysis of ZMYND10 expression in breast cancer cell lines and tissues.
• Assessing the impact of ZMYND10 re-expression on cancer cell behavior (apoptosis, proliferation, migration, invasion) in vitro.
• Evaluating ZMYND10's effect on tumor growth in vivo using xenograft models.
• Investigating the molecular pathway involving ZMYND10, miR145-5p, and NEDD9.

Main Results:

• ZMYND10 expression is significantly decreased in breast cancer, correlating with promoter hypermethylation.
• Ectopic ZMYND10 expression induced apoptosis and suppressed proliferation, migration, and invasion in vitro.
• ZMYND10 expression inhibited xenograft tumor growth in vivo.
• ZMYND10 was found to upregulate miR145-5p, which in turn targets and suppresses NEDD9 expression by binding to the 3'-UTR of NEDD9 mRNA.

Conclusions:

• ZMYND10 suppresses breast cancer tumorigenicity via the miR145-5p/NEDD9 signaling pathway.
• This newly identified pathway represents a potential therapeutic target for developing novel breast cancer treatments.
• Targeting the miR145-5p/NEDD9 axis could offer a strategy to inhibit breast cancer metastasis.